Cargando…

COVID-19 vaccine wastage in low-income countries: What is the starting point?

Another aspect to take into consideration is vaccine accessibility. For centuries, the geographical barrier has been a critical barrier to accessing healthcare services in many rural areas. The situation was not so different as the COVID-19 vaccine never reached some remote areas. But even in the ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dor, Vanessa Jaëlle, Eveillard, Ronald, Satapathy, Prakasini, Padhi, Bijaya K., Sah, Ranjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485415/
https://www.ncbi.nlm.nih.gov/pubmed/36157133
http://dx.doi.org/10.1016/j.amsu.2022.104676
_version_ 1784792063718457344
author Dor, Vanessa Jaëlle
Eveillard, Ronald
Satapathy, Prakasini
Padhi, Bijaya K.
Sah, Ranjit
author_facet Dor, Vanessa Jaëlle
Eveillard, Ronald
Satapathy, Prakasini
Padhi, Bijaya K.
Sah, Ranjit
author_sort Dor, Vanessa Jaëlle
collection PubMed
description Another aspect to take into consideration is vaccine accessibility. For centuries, the geographical barrier has been a critical barrier to accessing healthcare services in many rural areas. The situation was not so different as the COVID-19 vaccine never reached some remote areas. But even in the urban ones, which are denser and more favorable for virus transmission, the vaccine delivery failed because of external factors unrelated to the vaccine itself. The recurrent gang violence and political unrest associated with natural disasters, such as the earthquake in the South part of Haïti in August 2021, prevented vaccine delivery by shifting the population priorities and disrupting or destroying the delivery system. Then, any delay in administering the vaccine to the target population increases the risk of vaccine expiration and wastage, as COVID-19 vaccines are known for having a limited shelf life.
format Online
Article
Text
id pubmed-9485415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94854152022-09-21 COVID-19 vaccine wastage in low-income countries: What is the starting point? Dor, Vanessa Jaëlle Eveillard, Ronald Satapathy, Prakasini Padhi, Bijaya K. Sah, Ranjit Ann Med Surg (Lond) Editorial Another aspect to take into consideration is vaccine accessibility. For centuries, the geographical barrier has been a critical barrier to accessing healthcare services in many rural areas. The situation was not so different as the COVID-19 vaccine never reached some remote areas. But even in the urban ones, which are denser and more favorable for virus transmission, the vaccine delivery failed because of external factors unrelated to the vaccine itself. The recurrent gang violence and political unrest associated with natural disasters, such as the earthquake in the South part of Haïti in August 2021, prevented vaccine delivery by shifting the population priorities and disrupting or destroying the delivery system. Then, any delay in administering the vaccine to the target population increases the risk of vaccine expiration and wastage, as COVID-19 vaccines are known for having a limited shelf life. Elsevier 2022-09-20 /pmc/articles/PMC9485415/ /pubmed/36157133 http://dx.doi.org/10.1016/j.amsu.2022.104676 Text en © 2022 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Dor, Vanessa Jaëlle
Eveillard, Ronald
Satapathy, Prakasini
Padhi, Bijaya K.
Sah, Ranjit
COVID-19 vaccine wastage in low-income countries: What is the starting point?
title COVID-19 vaccine wastage in low-income countries: What is the starting point?
title_full COVID-19 vaccine wastage in low-income countries: What is the starting point?
title_fullStr COVID-19 vaccine wastage in low-income countries: What is the starting point?
title_full_unstemmed COVID-19 vaccine wastage in low-income countries: What is the starting point?
title_short COVID-19 vaccine wastage in low-income countries: What is the starting point?
title_sort covid-19 vaccine wastage in low-income countries: what is the starting point?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485415/
https://www.ncbi.nlm.nih.gov/pubmed/36157133
http://dx.doi.org/10.1016/j.amsu.2022.104676
work_keys_str_mv AT dorvanessajaelle covid19vaccinewastageinlowincomecountrieswhatisthestartingpoint
AT eveillardronald covid19vaccinewastageinlowincomecountrieswhatisthestartingpoint
AT satapathyprakasini covid19vaccinewastageinlowincomecountrieswhatisthestartingpoint
AT padhibijayak covid19vaccinewastageinlowincomecountrieswhatisthestartingpoint
AT sahranjit covid19vaccinewastageinlowincomecountrieswhatisthestartingpoint